Trust Point Inc. Cuts Stock Position in Addus HomeCare Co. (NASDAQ:ADUS)

Trust Point Inc. trimmed its position in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 46.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,715 shares of the company’s stock after selling 4,044 shares during the period. Trust Point Inc.’s holdings in Addus HomeCare were worth $591,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of ADUS. Cherry Creek Investment Advisors Inc. purchased a new position in shares of Addus HomeCare during the fourth quarter worth approximately $340,000. KBC Group NV raised its position in Addus HomeCare by 49.1% in the 4th quarter. KBC Group NV now owns 814 shares of the company’s stock worth $102,000 after purchasing an additional 268 shares during the period. Exchange Traded Concepts LLC lifted its stake in Addus HomeCare by 2.6% in the fourth quarter. Exchange Traded Concepts LLC now owns 5,923 shares of the company’s stock worth $742,000 after purchasing an additional 150 shares during the last quarter. Janney Montgomery Scott LLC boosted its position in Addus HomeCare by 0.9% during the fourth quarter. Janney Montgomery Scott LLC now owns 10,691 shares of the company’s stock valued at $1,340,000 after buying an additional 91 shares during the period. Finally, Dakota Wealth Management grew its stake in shares of Addus HomeCare by 24.2% during the fourth quarter. Dakota Wealth Management now owns 2,024 shares of the company’s stock valued at $254,000 after buying an additional 394 shares during the last quarter. Institutional investors own 95.35% of the company’s stock.

Insider Buying and Selling at Addus HomeCare

In other Addus HomeCare news, EVP Roberton James Stevenson sold 2,250 shares of the firm’s stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $121.00, for a total transaction of $272,250.00. Following the completion of the transaction, the executive vice president now owns 10,217 shares of the company’s stock, valued at approximately $1,236,257. This trade represents a 18.05 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO R Dirk Allison sold 12,500 shares of Addus HomeCare stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the transaction, the chief executive officer now owns 141,897 shares of the company’s stock, valued at $17,476,034.52. The trade was a 8.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 39,750 shares of company stock valued at $4,930,750. 4.60% of the stock is currently owned by company insiders.

Addus HomeCare Price Performance

Shares of NASDAQ ADUS opened at $123.02 on Wednesday. Addus HomeCare Co. has a 1 year low of $85.94 and a 1 year high of $136.72. The company’s 50-day moving average is $126.87 and its 200 day moving average is $127.42. The stock has a market capitalization of $2.23 billion, a P/E ratio of 28.15, a P/E/G ratio of 1.62 and a beta of 1.00.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The firm had revenue of $289.80 million during the quarter, compared to analyst estimates of $289.42 million. During the same quarter in the prior year, the company earned $1.03 EPS. The business’s revenue was up 7.1% compared to the same quarter last year. Research analysts anticipate that Addus HomeCare Co. will post 4.58 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the company. Macquarie reissued an “outperform” rating and issued a $139.00 target price on shares of Addus HomeCare in a research note on Monday, November 4th. JMP Securities started coverage on Addus HomeCare in a research note on Monday, December 16th. They set an “outperform” rating and a $150.00 price objective for the company. Citizens Jmp raised shares of Addus HomeCare to a “strong-buy” rating in a research note on Monday, December 16th. Royal Bank of Canada reiterated an “outperform” rating and set a $136.00 price target on shares of Addus HomeCare in a report on Thursday, November 14th. Finally, KeyCorp began coverage on shares of Addus HomeCare in a report on Friday, October 11th. They issued an “overweight” rating and a $150.00 price target on the stock. One research analyst has rated the stock with a sell rating, nine have assigned a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Addus HomeCare has a consensus rating of “Buy” and an average price target of $134.22.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.